Found: 35
Select item for more details and to access through your institution.
Response from the International Transporter Consortium.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Membrane transporters in drug development.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Cabotegravir + Rilpivirine Long-Acting: Overview of Injection Guidance, Injection Site Reactions, and Best Practices for Intramuscular Injection Administration.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 6, p. 1, doi. 10.1093/ofid/ofae282
- By:
- Publication type:
- Article
884. Patient Adherence to Long-Acting Injectable Cabotegravir + Rilpivirine Through 48 Weeks of Maintenance Therapy in the Phase 3 ATLAS and FLAIR Studies.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S20, doi. 10.1093/ofid/ofz359.043
- By:
- Publication type:
- Article
Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Monoclonal Antibody Tumor Disposition.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 679, doi. 10.3390/ijms23020679
- By:
- Publication type:
- Article
Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer Efficacy.
- Published in:
- AAPS Journal, 2022, v. 24, n. 3, p. 1, doi. 10.1208/s12248-022-00698-x
- By:
- Publication type:
- Article
The Journey to AAPS 2020: a Reflection from Strategic Planning to PharmSci 360.
- Published in:
- AAPS Journal, 2019, v. 21, n. 1, p. 1, doi. 10.1208/s12248-018-0273-y
- By:
- Publication type:
- Article
Steady-State Brain Concentrations of Antihistamines in Rats.
- Published in:
- Pharmacology, 2004, v. 72, n. 2, p. 92, doi. 10.1159/000079137
- By:
- Publication type:
- Article
The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 66, n. 2, p. 233, doi. 10.1111/j.1365-2125.2008.03184.x
- By:
- Publication type:
- Article
Expression of calmodulin-dependent enzymes in developing rat striatum is not affected by perturbation of dopaminergic systems.
- Published in:
- Synapse, 1991, v. 9, n. 2, p. 136, doi. 10.1002/syn.890090208
- By:
- Publication type:
- Article
First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus.
- Published in:
- BMC Pharmacology & Toxicology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/2050-6511-14-26
- By:
- Publication type:
- Article
Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus.
- Published in:
- BMC Pharmacology & Toxicology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/2050-6511-14-25
- By:
- Publication type:
- Article
New Frontiers: Approaches to Understand the Mechanistic Basis of Renal Toxicity.
- Published in:
- Toxicologic Pathology, 2018, v. 46, n. 8, p. 1002, doi. 10.1177/0192623318798599
- By:
- Publication type:
- Article
The journey to AAPS 2020: a reflection from strategic planning to PharmSci 360.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Drug Development Strategy in the United States: An Industrial View of DMPK.
- Published in:
- Acta Pharmaceutica Hungarica, 2021, v. 91, n. 3/4, p. 103, doi. 10.33892/aph.2021.91.103-105
- By:
- Publication type:
- Article
Beyond MABEL: An Integrative Approach to First in Human Dose Selection of Immunomodulators by the Health and Environmental Sciences Institute (HESI) Immuno‐Safety Technical Committee (ITC).
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 546, doi. 10.1002/cpt.3316
- By:
- Publication type:
- Article
Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 573, doi. 10.1002/cpt.2670
- By:
- Publication type:
- Article
Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 916, doi. 10.1002/cpt.1222
- By:
- Publication type:
- Article
Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 900, doi. 10.1002/cpt.1115
- By:
- Publication type:
- Article
Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96.
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 381, doi. 10.1111/hiv.13588
- By:
- Publication type:
- Article
Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long‐acting cabotegravir and rilpivirine in clinical trials.
- Published in:
- HIV Medicine, 2023, v. 24, n. 5, p. 568, doi. 10.1111/hiv.13439
- By:
- Publication type:
- Article
Long-Acting Cabotegravir+Rilpivirine Injection Site Reactions: Pooled Week 96 Results.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 277
- By:
- Publication type:
- Article
Asian Phase 3/3b Experience With Long-Acting Cabotegravir and Rilpivirine: Efficacy, Safety, and Virologic Outcomes Through Week 96.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 275
- By:
- Publication type:
- Article
Outcomes for participants during long-term follow-up after discontinuation of cabotegravir + rilpivirine long-acting in the phase III/IIIB clinical trials.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S306
- By:
- Publication type:
- Article
Efficacy and safety outcomes by BMI category over 48 weeks in phase 3/3B cabotegravir and rilpivirine long-acting trials.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S308
- By:
- Publication type:
- Article
PhRMA White Paper on ADME Pharmacogenomics.
- Published in:
- Journal of Clinical Pharmacology, 2008, v. 48, n. 7, p. 849, doi. 10.1177/0091270008319329
- By:
- Publication type:
- Article
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 10, p. 1423, doi. 10.1093/cid/ciad370
- By:
- Publication type:
- Article
Dispersed crude oil amplifies germ cell apoptosis in Caenorhabditis elegans, followed a CEP-1-dependent pathway.
- Published in:
- Archives of Toxicology, 2014, v. 88, n. 3, p. 543, doi. 10.1007/s00204-014-1198-6
- By:
- Publication type:
- Article
Chemical dispersant potentiates crude oil impacts on growth, reproduction, and gene expression in Caenorhabditis elegans.
- Published in:
- Archives of Toxicology, 2013, v. 87, n. 2, p. 371, doi. 10.1007/s00204-012-0936-x
- By:
- Publication type:
- Article
The Journey to AAPS 2020: a Reflection from Strategic Planning to PharmSci 360.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Expression of Calmodulin-Dependent Phosphodiesterase, Calmodulin-Dependent Protein Phosphatase, and Other Calmodulin-Binding Proteins in Human SMS-KCNR Neuroblastoma Cells.
- Published in:
- Journal of Neurochemistry, 1989, v. 52, n. 5, p. 1438, doi. 10.1111/j.1471-4159.1989.tb09191.x
- By:
- Publication type:
- Article
Practical dosing guidance for the management of clinician-administered injections of long-acting cabotegravir and rilpivirine.
- Published in:
- Therapeutic Advances in Infectious Disease, 2023, v. 10, p. 1, doi. 10.1177/20499361231214626
- By:
- Publication type:
- Article
Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 1, p. e34, doi. 10.1093/infdis/jiad580
- By:
- Publication type:
- Article
ZnO Nanoparticles Enhanced Germ Cell Apoptosis in Caenorhabditis elegans, in Comparison with ZnCl<sub>2</sub>.
- Published in:
- Toxicological Sciences, 2017, v. 156, n. 2, p. 336, doi. 10.1093/toxsci/kfw258
- By:
- Publication type:
- Article
Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer.
- Published in:
- Pharmaceutical Research, 2012, v. 29, n. 3, p. 770, doi. 10.1007/s11095-011-0601-8
- By:
- Publication type:
- Article